Aia kēia ʻaoʻao i ka ʻike hou e pili ana i ka COVID-19, nā ʻōlelo aʻo kūpono, nā wikiō a me nā loulou i ka ʻike pili.
Hoʻokaʻaʻike i ka Lymphoma Care Nurse Support Line – 1800 953 081.
Ke loli nei ka ʻike a me ka ʻōlelo aʻo e pili ana i ka COVID / Coronavirus i kēlā me kēia lā. E mālama pono i kou aupuni kūloko a me ka ʻōlelo aʻo olakino. ʻO ka ʻike ma kēia ʻaoʻao he ʻōlelo aʻoaʻo a me ka ʻike no nā maʻi lymphoma.
[Hoʻonui ʻia ka ʻaoʻao: 9 Iulai 2022]
NĀ ʻike a me nā ʻōlelo aʻoaʻo COVID-19 hou loa:
MAY 2022
Kauka Krispin Hajkowicz Hoʻohui ʻia ka Specialist maʻi Infectious e ka haematologist Kauka Andrea Henden a me Immunologist Kauka Michael Lane. Kūkākūkā lākou i nā lāʻau lapaʻau COVID ʻē aʻe i loaʻa, nā lāʻau prophylactic, nā ʻōlelo aʻoaʻo a me ka maikaʻi o ka maʻi. E nānā i ke wikiō ma lalo. Mei 2022
He aha ka COVID-19 (CORONAVIRUS)?
ʻO COVID-19 kahi maʻi hanu i hoʻokumu ʻia e kahi coronavirus hou (hou) i ʻike ʻia ma kahi maʻi maʻi ma Wuhan, Kina, i Dekemaba 2019. ʻO nā Coronaviruses kahi ʻohana nui o nā maʻi maʻi hiki ke hoʻoulu i nā maʻi maʻalahi, e like me ke anu maʻamau, ʻoi aku ka nui o nā maʻi, e like me Severe Acute Respiratory Syndrome (SARS).
Hiki i ka COVID-19 ke laha mai ke kanaka a i ke kanaka, ma o na kulu li'ili'i mai ka ihu a i ka waha paha e laha ana i ka wa a ke kanaka a me ke kihe. Hiki i kekahi kanaka ke hopu i ka COVID-19 ma ka hanu ʻana i loko o kēia mau kulu a i ʻole ka hoʻopā ʻana i kahi ʻili i kau ʻia ai nā kulu a laila hoʻopā i ko lākou mau maka, ihu a waha paha.
E like me ka hihia o nā maʻi maʻi āpau, hoʻololi ka maʻi COVID-19 me nā ʻano hoʻololi i ʻike ʻia me ka, alpha, beta, gamma, delta a me ka omicron strain.
Aia nā hōʻailona o COVID-19 ke kuni, ka mai, ka eha, ka hanu, ka ihu, ka poo, ka luhi, ka ma'i, ka eha kino, ka lua'i a me ka nausea, ka poho o ka honi a me ka ono.
He aha kāu e ʻike ai?
- ʻO ka loaʻa ʻana o kahi maʻi maʻi ʻino e like me Lymphoma/CLL e hoʻonui i kou pilikia o nā hoʻopiʻi koʻikoʻi inā ʻoe e ʻaelike iā COVID-19.
- Inā loaʻa iā ʻoe kekahi mau ʻano o ka lapaʻau immunosuppressive ʻaʻole paha ʻoe e kau i kahi pane anitbody ikaika i ke kano. Hōʻike nā haʻawina i nā poʻe maʻi i loaʻa i nā lāʻau lapaʻau anti-CD20 e like me rituximab a me obinutuzumab, ʻaʻole pane like i ka lāʻau lapaʻau. ʻO kēia hoʻi ka hihia no ka mea maʻi ma nā mea hoʻopaneʻe BTK (ibrutinib, acalabrutinib) a me nā mea hoʻopaneʻe kinase protein (venetoclax). Eia nō naʻe, nui ka poʻe me ka immunocompromise e kau mau i kahi pane ʻāpana i ke kano.
- ʻIke ʻo ATAGI i ka piʻi ʻana o ka pilikia i ko mākou kaiāulu nāwaliwali, no laila aia nā ʻōlelo aʻo ʻokoʻa i ka hoʻohālikelike ʻana i ka lehulehu. ʻO ka poʻe i ʻoi aku ma mua o 18 mau makahiki i loaʻa i ka papa kumu mua o ka maʻi maʻi he 3 mau kano e hiki ke loaʻa i ka 4th dose (booster) 4 mau mahina ma hope o ko lākou kolu.
COVID-19: Pehea e hōʻemi ai i ka pilikia o ka loaʻa ʻana o ka maʻi maʻi
Hiki i ka lāʻau lapaʻau no ka lymphoma & CLL ke hōʻemi i ka pono o ka ʻōnaehana pale. ʻOiai ke hoʻomau nei mākou e aʻo hou e pili ana i ka COVID-19 i kēlā me kēia lā, ua manaʻo ʻia ʻo ka poʻe maʻi me nā maʻi maʻi āpau a me nā poʻe ʻelemakule e ʻoi aku ka nui o ka maʻi maʻi me ka maʻi. ʻO ka poʻe i nāwaliwali nā ʻōnaehana pale ʻoi aku ka nui o ka pilikia o ka loaʻa ʻana o ka maʻi akā aia kekahi mau ʻanuʻu i hiki ke hana ʻia e hōʻemi ai i ka loaʻa ʻana o kahi maʻi.
HOOLAHA iā ʻoe iho a me kāu mau pilina pili
Holoi i ko oukou mau lima me ke kopa a me ka wai no 20 kekona a i ʻole e hoʻohana i ka holoi lima me ka waiʻona. Holoi i kou mau lima ke launa pū ʻoe me nā poʻe ʻē aʻe, ma mua o ka ʻai ʻana a i ʻole ke pā ʻana i kou mau maka, ma hope o ka hoʻohana ʻana i ka lumi ʻauʻau a i ke komo ʻana i kou home.
E HOOMAEMAE A HOOMAEMAE I KOU HOME e wehe i nā maʻi. E hoʻomaʻemaʻe maʻamau i nā mea i hoʻopā pinepine ʻia e like me; nā kelepona paʻa lima, nā pākaukau, nā kī puka, nā hoʻololi kukui, nā lima lima, nā pākaukau, nā halepaku a me nā paipu.
E MALAMA I KA PALAPALA ma waena o ʻoe iho a me nā mea ʻē aʻe. E mālama i ka hele ʻana ma waho o kou home ma ka waiho ʻana i hoʻokahi mika ka mamao ma waena o ʻoe a me nā poʻe ʻē aʻe
E ALOHA I KA POE INO Inā ʻoe ma ka lehulehu a ʻike ʻoe i kekahi e ʻuʻu/huhū a ʻike ʻole ʻia ʻo ia ka maʻi kino, e ʻoluʻolu e haʻalele iā lākou e pale iā ʻoe iho. E hōʻoia i ka hele ʻole ʻana o ka ʻohana/hoaaloha inā e hōʻike ana lākou i nā hōʻailona o ka maʻi e like me ke kuni, ka ʻū ʻana, ka ʻū, ke poʻo, a pēlā aku.
E HOOLOHE I NA LEHULEHU ʻoi aku ka maikaʻi ma nā wahi ʻino ʻole. Hiki ke piʻi aʻe kou pilikia o ka ʻike ʻana i nā maʻi hanu e like me COVID-19 i ka lehulehu, i pani ʻia me ka liʻiliʻi o ka ea inā he poʻe ma ka lehulehu ka maʻi.
E HAALELE I NA HUAKAI OLE A PAU me nā huakaʻi mokulele, a ʻoi aku ka pale ʻana i ka holo ʻana i nā moku holo moku.
KA MAHELE COVID-19
Aia ma Australia i keia manawa he 3 i aponoia; Pfizer, Moderna a me AstraZeneca.
- ʻAʻole ʻo Pfizer a me Moderna nā lāʻau lapaʻau ola. Loaʻa iā lākou kahi vector viral non-replika ʻaʻole hiki ke hoʻolaha i nā cell ʻē aʻe. ʻO Pfizer a me Moderna ka lāʻau lapaʻau i makemake ʻia no ka poʻe ma lalo o 60 mau makahiki a ʻo ia ke koho i makemake ʻia no ka poʻe me ka mōʻaukala o nā maʻi clotting.
- Hoʻopili ʻia ʻo AstraZeneca me kahi maʻi kakaʻikahi i kapa ʻia ka thrombosis me ka maʻi thrombocytopenia (TTS). ʻAʻohe mea hōʻike e pili ana kahi hōʻailona o ka lymphoma me ka piʻi nui o ka TTS.
Paipai ikaika ʻia ka lāʻau lapaʻau COVID-19 no ka poʻe i immunocompromised, akā no kekahi poʻe maʻi, pono ka noʻonoʻo ʻana i ka manawa kūpono o ka lāʻau lapaʻau. Pono paha ke kūkākūkā me kāu kauka lapaʻau.
ʻO ka papa hana o ka lāʻau lapaʻau i ʻāpono ʻia i kēia manawa no nā maʻi lymphoma/CLL, he papa kumu mua ia o 3 mau puʻupuʻu o ka lāʻau lapaʻau me ka hoʻoikaika ʻana, 4 mau mahina ma hope o ke kolu o ka maʻi.
UA LILO AKU I KA PONO....
Inā ʻike ʻoe i nā hōʻailona o COVID-19 pono ʻoe e hoʻāʻo a hoʻokaʻawale a hiki i ka hoʻi ʻana o kāu mau hopena. Loaʻa koke ʻia kahi papa inoa o nā kikowaena hoʻāʻo ma o kāu pūnaewele olakino aupuni kūloko. Inā ʻike ʻia ʻoe he neutropenic a i ʻole e mālama ʻia ana ʻoe e hana i ka neutropenia, a maʻi ʻole ʻoe a i ʻole e loaʻa i nā kuni. > 38C no 30min pono ʻoe e hahai i nā kaʻina hana maʻamau no ka febrile neutropenia a hōʻike i ke keʻena pilikia..
E hahai ana kēlā me kēia haukapila i kahi protocol koʻikoʻi no ka mālama ʻana i ka maʻi febrile i ka wā maʻi maʻi. Manaʻo ʻia e kāʻili ʻia a kaʻawale a hoʻi mai kāu mau hopena.
ʻO wau ʻo COVID-19 POSITIVE
- DO ʻAʻole e hele i ka haukapila inā hoʻihoʻi ʻoe i kahi hopena maikaʻi a he ASYMPTOMATIC. Eia nō naʻe, inā hoʻihoʻi ʻoe i kahi hopena swab COVID-19 maikaʻi, pono e haʻi koke i kāu mālama ʻana.
Inā maikaʻi ʻole ʻoe i nā mahana > 38C no 30min pono ʻoe e hahai i nā kaʻina hana maʻamau no ka febrile neutropenia a hōʻike i ke keʻena pilikia. Inā pilikia ʻoe i ka hanu a i ʻole ka ʻeha o ka umauma, pono ʻoe e hōʻike i ke keʻena pilikia.
Inā maikaʻi ʻoe me COVID-19, kūpono paha ʻoe no ka COVID-19 monoclonal antibody treaments. Ma Australia, aia ʻelua mau mea hana i ʻae ʻia no ka hoʻohana ʻana i ka heluna immunocompromised.
- ʻO Sotrovimab ua ʻae ʻia i nā maʻi ma mua o ka koi ʻana i ka oxygen a pono e lawelawe ʻia i loko o 5 mau lā ma hope o kahi hoʻokolohua maikaʻi.
- Casirivimab/ Imdevimab Hōʻike ʻia inā he asymptomatic ʻoe a i loko o 7 mau lā o ka hoʻāʻo maikaʻi ʻana.
KE MALAMA ANA I KEKAHI ME LYMPHOMA, Pehea wau e mālama ai iā lākou?
- E hoʻomaʻamaʻa i ka maʻemaʻe hanu maikaʻi ma ka uhi ʻana i kou waha a me ka ihu me ka kuʻekuʻe lima a i ʻole ka ʻiʻo i ka wā e ʻuʻu ai a ʻāhue paha, e hoʻolei koke i nā ʻiʻo i hoʻohana ʻia i loko o kahi pahu pani. E ʻoluʻolu, ʻaʻole pono ʻoe e ʻaʻahu i ka pale maka inā olakino ʻoe. E ho'āʻo a hoʻonohonoho i nā kahu mālama ʻē aʻe inā ʻaʻole ʻoe maʻi.
- E hoʻomaʻemaʻe i kou mau lima me ke kopa a me ka wai no 20 kekona.
- E pale aku i ka launa pū ʻana me ka mea i loaʻa i ke anu a i ʻole ka maʻi maʻi like ʻole;
- Inā manaʻo ʻoe ua loaʻa iā ʻoe nā hōʻailona coronavirus a i pili paha i kahi kanaka i loaʻa i ka coronavirus, pono ʻoe e kelepona i ka Coronavirus Health Information Line. Hoʻohana ka laina i nā hola 24 i ka lā, ʻehiku lā o ka pule (ma lalo).
He aha kaʻu lapaʻau ʻana a me koʻu hoʻokohu ʻana?
- Pono paha ʻoe e hoʻololi i ke keʻena lapaʻau a i ʻole nā manawa lapaʻau i ka manawa pōkole.
- Hiki ke hoʻololi ʻia nā koho kauka i ke kelepona a i ʻole ke kelepona olakino
- Ma mua o kou kipa ʻana i ka haukapila e noʻonoʻo inā ua kamaʻilio ʻoe me nā poʻe me ka poʻe i manaʻo ʻia he COVID-19 A inā he maʻi ʻole ʻoe me nā hōʻailona hanu e like me ka ʻuʻu, ke kuni, ka pōkole o ka hanu - e ʻike i kāu kikowaena maʻi maʻi.
NA HANA MA'I
ʻO ka ʻike o Trisha
ʻO ka hoʻopaʻa ʻana i ka COVID i ka wā e mālama ʻia ana (escalated BEACOPP)
ʻO kaʻike o Mina
Hoʻopaʻa ʻia ʻo COVID 4 mau mahina ma hope o ka mālama ʻana (Hodgkin Lymphoma)
Loulou Waihona Puke wikiō
Nā Hoʻohui Hoʻoili
ʻO ka laina ʻike olakino ʻo Coronavirus ma 1800 020 080
Ola Aupuni Australia - ʻO ka ʻike Coronavirus
Ua hoʻokuʻu ke Aupuni i nā kumuwaiwai koʻikoʻi e pili ana i ka coronavirus - e pili pū me kēia mau kumuwaiwai e hoʻomau i ka ʻike i nā hanana e hiki mai ana.
E kipa i ka punaewele o ka 'Oihana Ola maanei
Nā kikowaena no ka hoʻopaʻa ʻana a me ka pale ʻana i ka maʻi (ka honua)
https://www.cdc.gov/coronavirus/2019-ncov/index.html
No nā nīnau hou aku hiki iā ʻoe ke kelepona i ka Lymphoma Nurse Support Line T: 1800 953 081 a i ʻole leka uila: kahu@lymphoma.org.au
